Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2023-04-20 Sale |
2023-04-21 9:05 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operations Officer |
520,000 | $1.135 | $590,200 | 653,058 (Direct) |
View |
2022-06-21 Purchase |
2022-06-23 5:08 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
10,000 | $1.05 | $10,500 | 1,173,058 (Direct) |
View |
2021-12-06 Purchase |
2021-12-06 5:26 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
25,201 | $1.38 | $34,777 | 1,163,058 (Direct) |
View |
2021-12-03 Purchase |
2021-12-03 4:32 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
10,000 | $1.42 | $14,200 | 1,137,857 (Direct) |
View |
2021-02-23 Sale |
2021-02-25 8:51 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
15,900 | $2.088 | $33,199 | 1,127,857 (Direct) |
View |
2021-02-12 Sale |
2021-02-17 9:13 pm |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
63,700 | $2.55 | $162,435 | 1,143,757 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-04-17 Option Award |
2023-04-19 5:41 pm |
N/A 2033-04-17 |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operations Officer |
192,143 | $0 | 192,143 (Direct) |
View |
2022-03-31 Option Award |
2022-04-04 6:46 pm |
N/A 2031-12-21 |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
100,000 | $0 | 100,000 (Direct) |
View |
2021-12-21 Option Award |
2021-12-23 5:31 pm |
N/A 2031-12-21 |
Outlook Therapeutics Inc. | OTLK | Dagnon Terry Chief Operating Officer |
800,000 | $0 | 800,000 (Direct) |
View |